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Background: Few studies have examined the impact of childhood obesity on later kidney disease, and
consequently, our understanding is very limited.
Study Design: Longitudinal population-based cohort.
Setting & Participants: The Medical Research Council National Survey of Health and Development, a
socially stratified sample of 5,362 singletons born in 1 week in March 1946 in England, Scotland, and Wales, of
which 4,340 were analyzed.
Predictor: Early-life overweight latent classes (never, prepubertal only, pubertal onset, or always), derived
from repeated measurements of body mass index between ages 2 and 20 years.
Outcomes & Measurements: The primary outcome was chronic kidney disease (CKD), defined as
creatinine- or cystatin C–based estimated glomerular filtration rate (eGFRcr and eGFRcys, respectively) 60
mL/min/1.73 m2 or urine albumin-creatinine ratio (UACR) 3.5 mg/mmol measured at age 60-64 years.
Associations were explored through regression analysis, with adjustment for socioeconomic position, smoking,
physical activity level, diabetes, hypertension, and overweight at ages 36 and 53 years.
Results: 2.3% of study participants had eGFRcr60 mL/min/1.73 m2, 1.7% had eGFRcys60 mL/min/1.73
m2, and 2.9% had UACR 3.5 mg/mmol. Relative to being in the never-overweight latent class, being in the
pubertal-onset– or always-overweight latent classes was associated with eGFRcys-defined CKD (OR, 2.04;
95% CI, 1.09-3.82). Associations with CKD defined by eGFRcr (OR, 1.27; 95% CI, 0.71-2.29) and UACR (OR,
1.33; 95% CI, 0.70-2.54) were less marked, but in the same direction. Adjustment for lifestyle and health factors
had little impact on effect estimates.
Limitations: A low prevalence of CKD resulted in low statistical power. No documentation of chronicity for
outcomes. All-white study population restricts generalizability.
Conclusions: Being overweight in early life was found to be associated with eGFRcys-defined CKD in later
life. The associations with CKD defined by eGFRcr and UACR were less marked, but in the same direction.
Reducing or preventing overweight in the early years of life may significantly reduce the burden of CKD in the
population.
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Open access under CC BY license.During recent decades, the prevalence of over-weight and obesity has increased dramatically
in many parts of the world,1 with further increases
predicted in the coming years.2 Of particular concern
is the growing global childhood obesity epidemic.3
Globally increasing cardiovascular mortality4 to-
gether with the recognition of kidney disease as a
cardiovascular risk factor5 has led to greater interest
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276in the relationship between obesity and kidney dis-
ease. A growing number of studies have concluded
that adulthood obesity increases the risk of kidney
disease6 and numerous studies have tracked obesity
from childhood into adulthood.7 However, not many
studies have directly examined the effect of childhood
obesity on the risk of kidney disease, and conse-
quently, our understanding is limited. A review of 6
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Childhood Overweight and CKD at Age 60-64such studies determined that childhood obesity is
associated with an elevated risk of kidney disease, as
well as its progression and mortality,8 but all these
studies were conducted in patients already with kid-
ney disease rather than the general population. A more
recent study of 1.2 million Israelis found overweight
and obesity at age 17 years to be associated with a
significantly increased risk of all-cause end-stage re-
nal disease in a 25-year period.9
We previously have found overweight in adult-
hood, particularly overweight starting in early adult-
hood, to be associated with reduced kidney function
later in life in the Medical Research Council (MRC)
National Survey of Health and Development (NSHD).10 In
the present study, we extend our previous work to
explore whether the increase in risk associated with
overweight stretches back even farther, into early life.
We used repeated measurements of body mass index
(BMI) between ages 2 and 20 years to model early-
life overweight trajectories, which we then related to
measures of chronic kidney disease (CKD) at age
60-64 years.
METHODS
Participants
The NSHD is a socially stratified sample of 5,362 singletons
born in 1 week in March 1946 in England, Scotland, and Wales
who have been followed up many times since birth.11 Between
October 2006 and February 2011 (when members of the cohort
were aged 60-64 years), 2,856 eligible study participants (those
known to be alive and with a known address in England, Scotland,
or Wales) were invited for an assessment at 1 of 6 clinical research
facilities. If they were unable or unwilling to come to one of the
clinical research facilities, they were offered a slightly less compre-
hensive examination carried out in their own home by a trained
nurse. Of those invited, 2,229 (78.0%) were assessed: 1,690
(59.2%) attended a clinic and 539 (18.9%) had a home visit.12
Measures
Height and weight were measured at ages 2, 4, 6, 7, 11, and 15
according to standard protocols and self-reported at age 20 years.
BMI, defined as weight in kilograms divided by height in meters
squared, was calculated at each age. We then used the interna-
tional overweight cutoffs of Cole et al13 to determine the
corresponding overweight status at each age. For clarity, those
identified as overweight by this approach include both those
traditionally labeled overweight and those labeled obese. Fur-
thermore, in this report, we use the term overweight as a noun,
as is customary with obese.
At the clinic or home visit at age 60-64 years, blood and urine
samples were obtained and processed according to standardized
protocols. Serum creatinine was measured by means of a kinetic
version of the Jaffé method using a Siemens Dimension Xpand
analyzer at the MRC Human Nutrition Research laboratory in
Cambridge. A method-specific correction, specified by the UK
National External Quality Assessment Service, was applied to
standardize measured values to the reference method (isotope-
dilution mass spectrometry). Cystatin C was measured by an
automated particle-enhanced immunoturbidimetric assay at the
Department of Clinical Biochemistry at the Glasgow Royal Infir-
Am J Kidney Dis. 2013;62(2):276-284mary. Urine creatinine was measured using a kinetic version of the
Jaffé method on a Siemens Dimension analyzer, and urinary
albumin was measured by an immunoturbidimetric method on a
Siemens BNII/ProSpec analyzer at the MRC Human Nutrition
Research laboratory in Cambridge.
Creatinine- and cystatin Cbased estimated glomerular filtra-
tion rate (eGFRcr and eGFRcys, respectively) were calculated using
the CKD Epidemiology Collaboration (CKD-EPI) formulas dating
from 2009 and 2012, respectively.14,15 Urine albumin-creatinine
ratio (UACR) was calculated with adjustment for storage time.
Based on KDIGO (Kidney Disease: Improving Global Out-
comes) criteria,16 we defined CKD as either: (1) eGFRcr 60
mL/min/1.73 m2, (2) eGFRcys60 mL/min/1.73 m2, or (3) UACR
3.5 mg/mmol. We analyzed each of these CKD outcomes sepa-
rately, as well as a composite measure that indicated whether CKD
was present on any one or more of the CKD outcomes. As a
secondary outcome, we also analyzed cystatin C.
Several lifestyle and health factors were considered as potential
confounders or mediators of the association between overweight
trajectory during ages 2-20 years and later CKD: childhood socio-
economic position (SEP; manual labor/blue collar work vs non-
manual labor/white collar work) was derived from the father’s
occupation when the study participant was aged 4 years; adulthood
SEP (as described) was defined as the highest occupational class
derived from the study participant’s and spouse’s occupations at
age 53 years; previously derived smoking trajectory between ages
20 and 53 years17; previously derived physical activity latent
classes between ages 31 and 53 years18; diabetes (self-reported
physician-diagnosed diabetes by age 60-64 years, on diabetes
medication at age 60-64 years, and hemoglobin A1c level at age
60-64 years); and hypertension (previously derived systolic blood
pressure latent trajectory between ages 36 and 53 years,19 on blood
pressure medication at age 60-64 years, and measured systolic
blood pressure at age 60-64 years).
Overweight at ages 36 and 53 years was considered as potential
mediators. Height and weight, measured at ages 36 and 53 years
using standard protocols, were used to calculate BMI, with over-
weight defined as BMI25 kg/m2.
Statistical Analyses
We first conducted longitudinal latent class analysis on the
overweight indicator variables between ages 2 and 20 years. The
objective of longitudinal latent class analysis is to decide how
many latent classes are required to describe the data and categorize
individuals into their most likely classes given their observed
measurements. Analyses were restricted to study members with at
least one BMI measurement between ages 2 and 20 years. Data
missingness was handled using full information maximum likeli-
hood under the assumption of missing at random.20
Patterns of early-life (ages 2-20 years) overweight were found to
differ between males and females, so separate longitudinal latent
class analyses were conducted. We used a variety of different tools
to decide how many classes were required because no single
approach is commonly accepted.21 Posterior probabilities were
derived to quantify the probability with which an individual with a
given early-life overweight pattern belonged to each latent class.
We investigated to what extent the latent classes were associated
with birth weight.
MainAnalyses
To account for the potential bias caused by missing data, we
conducted our analyses using a multiple imputation approach.22,23
In addition to all variables included in the analysis models, the
imputation model also included occupation at other ages in adult-
hood, further repeated measures of adulthood BMI, repeated
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Silverwood et almeasures of adulthood waist to hip ratio, birth weight, achieved
educational levels of the study member and their parents, and
response at the age 60- to 64-year data collection (eg, clinic/home
visit, temporary/permanent refusal, and untraced). Interactions
with sex were included in the imputation model for all variables.
Study members who were known to have died prior to or during
the age 60- to 64-year data collection were excluded from the
multiple imputation analysis. Fifty imputed data sets were ob-
tained through chained equations.24,25
Each of the 4 binary CKD outcomes was related to the resultant
overweight latent classes using logistic regression, weighted by the
longitudinal latent class analysis posterior class membership prob-
abilities and minimally adjusted for sex and age at CKD measure-
ments.
With the exception of childhood SEP, identifying lifestyle vari-
ables (SEP, smoking, and physical activity) as either potential
confounders or mediators of the association between early-life
overweight and later CKD is not straightforward. However, adult-
hood diabetes and hypertension more clearly are potential media-
tors of the association of interest. The extent to which these
lifestyle and health factors confounded or mediated the association
between early-life overweight and later CKD was examined by
adding, in turn, childhood and adulthood SEP, lifetime smoking
trajectory, midadulthood physical activity levels, diabetes (all 3
variables), hypertension (all 3 variables), and finally, all lifestyle
and health factors to the minimally adjusted models.
The extent to which the association between early-life over-
weight and later CKD was mediated by adulthood overweight was
examined by adding, in turn, overweight at age 36 years and
overweight at age 53 years to the minimally adjusted models.
SupplementaryAnalyses
Cystatin C level was related to the early-life overweight latent
classes using linear regression, again weighted by the longitudinal
latent class analysis posterior class membership probabilities and
minimally adjusted for sex and age at the CKD measurements.
All analyses then were repeated using only complete cases for
comparison with multiple imputation results.
No interactions between sex and early-life overweight latent
class were found in any model, so combined male and female
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Figure 1. Early-life overweight latent class profiles for males
(n  2,564). Solid line and circles, never overweight (71.4%);
dashed line and diamonds, prepubertal-only overweight (21.0%);
dotted line and triangles, pubertal-onset overweight (5.0%); and
dot-dashed line and squares, always overweight (2.7%).models are presented throughout.
278The longitudinal latent class analysis was conducted using
Mplus 6 (Muthén & Muthén), with the remaining analysis, includ-
ing the multiple imputation, performed using Stata 12 (StataCorp).
RESULTS
StudyParticipants andLongitudinal Latent Class
Analysis
A flow diagram showing inclusion in the early-life
(ages 2-20 years) overweight longitudinal latent class
analysis and multiple imputation analysis is shown in
Fig S1 (provided as online supplementary material).
Of the original 5,362 study members in the cohort,
4,884 had at least one BMI measurement between
ages 2 and 20 years and were included in the longitu-
dinal latent class analysis. Of these, 77.6% had at least
5 of the 7 BMI measurements. The prevalence of
early-life overweight decreased from 35.1% at age 2
years to 7.1% at age 7 years before increasing to
12.6% at age 20 years (Table S1).
In the longitudinal latent class analysis, all metrics
suggested that 4 early-life overweight latent classes
were required for both males and females (results not
shown). These patterns of early-life overweight can
be considered as never (71.4% of males and 80.6% of
females), prepubertal only (21.0% and 8.9%), puber-
tal onset (5.0% and 6.6%), and always (2.7% and
3.9%; Figs 1 and 2). Males and females in the never-
overweight latent class had the lowest average birth
weight (3.44 and 3.30 kg, respectively), and those in
the always-overweight class had the highest (3.68 and
3.49 kg), with birth weights in the prepubertal-only
(3.60 and 3.47 kg) and pubertal-onset (3.61 and 3.39
kg) overweight classes falling in between.
The observed overall prevalence of CKD varied
between the different measures, from 1.7% (eGFRcys)
to 2.9% (UACR). Median cystatin C level was 0.81
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Figure 2. Early-life overweight latent class profiles for females
(n  2,320). Solid line and circles, never overweight (80.6%);
dashed line and diamonds, prepubertal-only overweight (8.9%);
dotted line and triangles, pubertal-onset overweight (6.6%); and
dot-dashed line and squares, always overweight (3.9%).
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Childhood Overweight and CKD at Age 60-64(interquartile range, 0.16) mg/L. Overall distributions
of all variables included in the analysis are listed in
Table 1.
The prevalence of CKD differed between the early-
Table 1. Distributions of Variables Stratified by Ea
Probability of
No. With
Available Data
Tota
(N  4,8
Age at examinationb (y) 2,197 63.6 [1
eGFRcr at age 60-64 y (mL/min/1.73 m2) 1,826 96.0 [1
eGFRcys at age 60-64 y (mL/min/1.73 m2) 2,022 96.9 [1
UACR at age 60-64 y (mg/mmol) 2,141 0.55 [0
Cystatin C at age 60-64 y (mg/L) 2,023 0.81 [0
HbA1c at age 60-64 y (%) 2,014 5.7 [0
SBP at age 60-64 y (mm Hg) 2,177 133 [2
eGFRcr60 mL/min/1.73 m2 at
age 60-64 y
1,826 2.3
eGFRcys60 mL/min/1.73 m2 at
age 60-64 y
2,022 1.7
UACR 3.5 mg/mmol at age 60-64 y 2,141 2.9
CKD by composite measure at
age 60-64 y
1,799 5.5
Manual labor/blue collar work
Study member’s parents 4,473 59.2
Study member at age 53 y 2,828 21.0
Lifetime smoking trajectory 3,352
Never smoker 28.0
Predominantly nonsmoker 32.6
Predominantly smoker 21.0
Lifelong smoker 18.3
Time sitting down during day at age 36 y 3,238
Much 26.4
Average 34.3
Little 39.3
Low walking latent class at age 36-43 y 3,522 41.8
Low cycling latent class at age 31-43 y 3,711 87.4
Leisure time physical activity latent class
at age 36-53 y
3,601
Low 46.8
Gardening and DIY 18.2
Sport and leisure 35.0
Self-reported diabetes by age 60-64 y 2,417 7.5
Receiving diabetes treatment at
age 60-64 y
2,585 5.5
Increased/high midlife SBP trajectory 3,589 6.5
Receiving antihypertensive treatment at
age 60-64 y
2,585 29.7
Overweight at age 36 y 3,233 35.0
Overweight at age 53 y 2,895 66.8
Note: With the exception of study members being given as number, valu
in lower section are given as percentage.
Abbreviations: CKD, chronic kidney disease; DIY, do-it-yourself activ
cystatin Cbased estimated glomerular filtration rate; HbA1c, hemoglobin
aOf original 5,362 study members in cohort, 4,884 had one or more bod
longitudinal latent class analysis.
bThe examination in question occurred between October 2006 and Febrlife BMI latent classes (Table 1). For both eGFRcr and
Am J Kidney Dis. 2013;62(2):276-284eGFRcys, the lowest prevalence was in the never-
overweight latent class (2.0% and 1.4%, respec-
tively), with the highest prevalence in the pubertal-
onset overweight latent class (4.6% and 5.3%). For
fe Overweight Latent Class, Weighted by Posterior
Membership
Early-Life Overweight
Never
(n  4,037)
Prepubertal Only
(n  491)
Pubertal Onset
(n  209)
Always
(n  147)
63.6 [1.3] 63.7 [1.5] 63.7 [1.6] 63.6 [1.3]
96.3 [16.1] 95.5 [16.4] 94.6 [16.2] 96.8 [18.5]
96.9 [18.8] 98.3 [18.9] 92.1 [20.5] 96.4 [19.1]
0.54 [0.43] 0.54 [0.40] 0.61 [0.50] 0.62 [0.53]
0.81 [0.16] 0.81 [0.16] 0.84 [0.18] 0.82 [0.14]
5.7 [0.5] 5.7 [0.4] 5.7 [0.6] 5.7 [0.5]
132 [22] 133 [22] 135 [23] 134 [21]
2.0 2.3 4.6 2.9
1.4 1.7 5.3 3.2
2.9 2.5 4.5 1.8
5.1 5.0 11.9 5.8
58.9 59.8 63.9 56.4
20.4 23.6 25.6 15.3
28.6 25.8 27.5 26.5
32.7 32.4 30.2 36.5
20.9 21.6 19.9 24.7
17.8 20.3 22.5 12.3
26.0 27.5 27.8 27.5
34.5 34.9 30.1 35.3
39.5 37.7 42.2 37.2
41.1 44.6 43.9 42.9
87.4 86.9 87.7 89.8
46.4 46.7 53.3 44.9
17.5 20.2 19.9 20.8
36.1 33.1 26.9 34.3
6.8 7.4 12.8 14.0
5.0 5.6 7.6 13.1
6.7 4.9 6.6 8.9
29.2 28.4 35.1 36.3
28.9 44.0 68.4 75.4
63.2 73.2 85.8 87.7
pper section of table are given as median [interquartile range] and values
eGFRcr, creatinine-based estimated glomerular filtration rate; eGFRcys,
BP, systolic blood pressure; UACR, urinary albumin-creatinine ratio.
s index measurement between ages 2 and 20 years and were included in
011, when cohort members were aged 60-64 years.rly-Li
Class
l
84a)
.3]
6.3]
9.0]
.44]
.16]
.5]
2]
es in u
ities;
A1c; S
y masUACR, the highest prevalence similarly was in the
279
Silverwood et alpubertal-onset overweight latent class (4.5%), al-
though the lowest prevalence was in the always-
overweight latent class (1.8%). Distributions of all
variables included in the analysis within each early-
life BMI latent class also are listed in Table 1.
There were very few study participants in the
always-overweight latent class with CKD, so for
the purpose of the remaining analyses, the pubertal-
onset and always-overweight latent classes were
combined. However, although there was insuffi-
cient power to formally test it, there was a sugges-
tion that CKD risk was greater in the pubertal-onset
overweight latent class than in the always-over-
weight latent class.
MainAnalyses
As shown in Fig S1, 4,340 study members were
eligible for both the longitudinal latent class analysis
and multiple imputation procedures and were in-
cluded in the analysis. There was evidence that,
relative to being in the never-overweight latent
class, being in the pubertal-onset or always-
overweight latent classes was associated with CKD
defined using eGFRcys (odds ratio [OR], 2.04; 95%
confidence interval [CI], 1.09-3.82; Table 2, model
Table 2. ORs for CKD at Age 60-64 Years b
CKD Definition and Early-Life
Overweight Latent Class
Percentage in Latent
Class
Totald With CKDd OR (9
CKD by eGFRcr
Never 76.0 3.5 1.00 (re
Prepubertal only 15.1 3.6 1.00 (0.
Pubertal onset/always 8.9 4.5 1.27 (0.
CKD by eGFRcys
Never 76.0 2.0 1.00 (re
Prepubertal only 15.1 2.1 1.21 (0.
Pubertal onset/always 8.9 4.1 2.04 (1.
CKD by UACR
Never 76.0 2.7 1.00 (re
Prepubertal only 15.1 2.8 0.93 (0.
Pubertal onset/always 8.9 3.6 1.33 (0.
Composite CKD measure
Never 76.0 7.3 1.00 (re
Prepubertal only 15.1 7.4 0.99 (0.
Pubertal onset/always 8.9 10.7 1.51 (1.
Note: Multiple imputation analysis (n 4,340).
Abbreviations and definitions: CI, confidence interval; CKD, c
UACR 3.5 mg/mmol); eGFRcr, creatinine-based estimated glom
lar filtration rate; OR, odds ratio; UACR, urinary albumin-creatinin
aModel 1: adjusted for sex and age at CKD measurements.
bModel 2: adjusted for sex, age at CKD measurements, and ch
cModel 3: adjusted for sex, age at CKD measurements, and life
dAverage across all 50 imputed data sets.1). The associations when considering eGFRcr (OR,
2801.27; 95% CI, 0.71-2.29) and UACR (OR, 1.33;
95% CI, 0.70-2.54) were less marked, but in the
same direction. There also was evidence of an
association with the composite CKD measure (OR,
1.51; 95% CI, 1.03-2.20). For none of the outcomes
was there evidence that being in the prepubertal-
only overweight latent class increased the risk of
reduced kidney function relative to the never-
overweight latent class.
Adjustment for lifestyle and health factors had little
impact on effect estimates (Tables 2 and 3). Adjust-
ment for diabetes and hypertension generally resulted
in the greatest attenuation. In the fully adjusted mod-
els (Table 3, model 7), there remained some evidence
of an association with CKD defined using eGFRcys
(OR, 1.88; 95% CI, 0.99-3.58) or the composite
measure (OR, 1.39; 95% CI, 0.94-2.04).
All effect estimates showed greater attenuation
when adjusted for overweight at age 36 years than
when adjusted for overweight at age 53 years (Table
4). For example, the composite CKD measure OR for
pubertal onset or always overweight was attenuated
from 1.51 to 1.18 on adjustment for overweight at age
36 years, but to only 1.39 on adjustment for over-
ly-Life Overweight Latent Class, Models 1-3
l 1a Model 2b Model 3c
I) P OR (95% CI) P OR (95% CI) P
ce) — 1.00 (reference) — 1.00 (reference) —
.53) 0.9 1.00 (0.66-1.52) 0.9 1.00 (0.66-1.53) 0.9
.29) 0.4 1.26 (0.70-2.27) 0.4 1.27 (0.70-2.29) 0.4
ce) — 1.00 (reference) — 1.00 (reference) —
.11) 0.5 1.20 (0.69-2.07) 0.5 1.19 (0.68-2.08) 0.5
.82) 0.03 1.98 (1.06-3.70) 0.03 2.00 (1.06-3.79) 0.03
ce) — 1.00 (reference) — 1.00 (reference) —
.42) 0.7 0.93 (0.60-1.42) 0.7 0.92 (0.60-1.41) 0.7
.54) 0.4 1.32 (0.69-2.53) 0.4 1.32 (0.69-2.52) 0.4
ce) — 1.00 (reference) — 1.00 (reference) —
.34) 0.9 0.99 (0.74-1.33) 0.9 0.99 (0.74-1.33) 0.9
.20) 0.03 1.49 (1.02-2.17) 0.04 1.50 (1.02-2.19) 0.04
ic kidney disease (eGFRcr or eGFRcys 60 mL/min/1.73 m2 or
ar filtration rate; eGFRcys, cystatin C–based estimated glomeru-
io.
od and adulthood socioeconomic position.
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Being in the pubertal-onset or always-overweight
latent classes also was associated with a 0.027 (95%
CI, 0.007-0.048) mg/L increase in cystatin C level
relative to being in the never-overweight latent class
(Table S2a). Adjustment for lifestyle and health fac-
tors again had little impact on this effect estimate
(Table S2a and b), and it showed greater attenuation
when adjusted for overweight at age 36 years than
when adjusted for overweight at age 53 years (Table
S2c).
Complete case analyses of the binary CKD out-
comes included between 1,799 (composite CKD mea-
sure) and 2,141 (UACR) study members. Estimated
associations between early-life overweight latent class
and later CKD were stronger than those in the mul-
tiple imputation analysis for eGFRcr and eGFRcys, but
similar for UACR (Table S3a). However, the CIs were
much wider due to the reduced sample size. There
remained strong evidence of associations for eGFRcys
and the composite CKD measure, with associations
for eGFRcr and UACR less marked but in the same
direction. Additional adjustment for lifestyle factors
again resulted in little attenuation of the effect esti-
mates (Table S3b and c). As in the multiple imputation
Table 3. ORs for CKD at Age 60-64 Years b
CKD Definition and Early-Life
Overweight Latent Class
Model 4a
OR (95% CI) P OR (9
CKD by eGFRcr
Never 1.00 (reference) — 1.00 (re
Prepubertal only 1.00 (0.66-1.53) 0.9 1.01 (0
Pubertal onset/always 1.27 (0.70-2.29) 0.4 1.23 (0
CKD by eGFRcys
Never 1.00 (reference) — 1.00 (re
Prepubertal only 1.22 (0.70-2.12) 0.5 1.23 (0
Pubertal onset/always 2.04 (1.08-3.85) 0.03 1.97 (1
CKD by UACR
Never 1.00 (reference) — 1.00 (re
Prepubertal only 0.93 (0.60-1.42) 0.7 0.93 (0
Pubertal onset/always 1.29 (0.67-2.47) 0.4 1.26 (0
Composite CKD measure
Never 1.00 (reference) — 1.00 (re
Prepubertal only 1.00 (0.74-1.34) 0.9 1.00 (0
Pubertal onset/always 1.48 (1.02-2.17) 0.04 1.45 (0
Note: Multiple imputation analysis (n 4,340).
Abbreviations and definitions: CI, confidence interval; CKD, chr
m2 or urine ACR3.5 mg/mmol); eGFRcr, creatinine-based estim
glomerular filtration rate; OR, odds ratio; UACR, urinary albumin-
aModel 4: adjusted for sex, age at CKD measurements, and m
bModel 5: adjusted for sex, age at CKD measurements, and dia
cModel 6: adjusted for sex, age at CKD measurements, and hy
dModel 7: adjusted for sex, age at CKD measurements, childho
midadulthood physical activity trajectories, diabetes, and hyperteanalysis, all effect estimates showed greater attenua-
Am J Kidney Dis. 2013;62(2):276-284tion when adjusted for overweight at age 36 years
than when adjusted for overweight at age 53 years
(Table S3d).
Complete case results for cystatin C were in line
similarly with the multiple imputation results (Table
S4a-d).
DISCUSSION
In a large population-based prospective study, we
found that overweight throughout early life or becom-
ing overweight in the period from puberty to age 20
years was associated with CKD at age 60-64 years
assessed using eGFRcys. This association was sup-
ported by less marked associations with eGFRcr and
UACR. Confounding or mediation by childhood and
adulthood SEP, lifetime smoking trajectory, and
midadulthood physical activity levels did not explain
the observed associations, and mediation by diabetes
and hypertension was limited.
The associations were attenuated to a far greater
extent when adjusted for overweight at age 36 years
than when adjusted for overweight at age 53 years.
This suggests that: (1) being overweight in early
adulthood is particularly harmful for later CKD (cor-
responding to our previous findings in this cohort10),
ly-Life Overweight Latent Class, Models 4-7
l 5b Model 6c Model 7d
I) P OR (95% CI) P OR (95% CI) P
ce) — 1.00 (reference) — 1.00 (reference) —
.54) 0.9 1.02 (0.67-1.55) 0.9 1.02 (0.67-1.56) 0.9
.23) 0.5 1.23 (0.68-2.23) 0.5 1.20 (0.66-2.19) 0.5
ce) — 1.00 (reference) — 1.00 (reference) —
.14) 0.5 1.23 (0.71-2.13) 0.5 1.20 (0.69-2.12) 0.5
.69) 0.03 1.96 (1.04-3.67) 0.04 1.88 (0.99-3.58) 0.06
ce) — 1.00 (reference) — 1.00 (reference) —
.43) 0.7 0.94 (0.61-1.45) 0.8 0.94 (0.61-1.45) 0.8
.41) 0.5 1.24 (0.65-2.39) 0.5 1.18 (0.61-2.27) 0.6
ce) — 1.00 (reference) — 1.00 (reference) —
.35) 0.9 1.01 (0.75-1.36) 0.9 1.01 (0.75-1.36) 0.9
.13) 0.06 1.44 (0.98-2.11) 0.06 1.39 (0.94-2.04) 0.1
kidney disease (defined as eGFRcr or eGFRcys60 mL/min/1.73
glomerular filtration rate; eGFRcys, cystatin C–based estimated
inine ratio.
lthood physical activity trajectories.
s.
nsion.
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Silverwood et alhave independent effects on CKD risk. However, this
finding also may be due in part to the stronger associa-
tion of early-life overweight with overweight at age
36 years than overweight at age 53 years.
To our knowledge, there are no existing studies of
the effect of overweight throughout early life on later
kidney disease in general population cohorts. In a
review of studies examining the association between
obesity and kidney disease, Wang et al8 identified 6
cohort studies in youth, all of which involved partici-
pants who were either kidney disease patients or
transplant recipients. In addition, the variety of out-
comes and relatively short follow-up periods make
direct comparison with the present study difficult.
Wang et al8 concluded that high BMI or obesity in
early life is associated with an increased risk of
kidney disease. This finding is certainly not at odds
with ours.
In a recent large population-based cohort study,
Vivante et al9 found overweight and obesity at age 17
years to be associated with significantly increased risk
of all-cause end-stage renal disease in a 25-year
period. Although their adjusted hazard ratios of 3.00
(95% CI, 2.50-3.60) for overweight and 6.89 (95%
CI, 5.52-8.59) for obesity appear somewhat stronger
Table 4. ORs for CKD at Age 60-64 Years by Early-Life
CKD Definition and Early-Life
Overweight Latent Class
Model 1a
OR (95% CI) P
CKD by eGFRcr
Never 1.00 (reference) —
Prepubertal only 1.00 (0.66-1.53) 0.9
Pubertal onset/always 1.27 (0.71-2.29) 0.4
CKD by eGFRcys
Never 1.00 (reference) —
Prepubertal only 1.21 (0.70-2.11) 0.5
Pubertal onset/always 2.04 (1.09-3.82) 0.03
CKD by UACR
Never 1.00 (reference) —
Prepubertal only 0.93 (0.60-1.42) 0.7
Pubertal onset/always 1.33 (0.70-2.54) 0.4
Composite CKD measure
Never 1.00 (reference) —
Prepubertal only 0.99 (0.74-1.34) 0.9
Pubertal onset/always 1.51 (1.03-2.20) 0.03
Note: Multiple imputation analysis (n 4,340).
Abbreviations and definitions: CI, confidence interval; CKD, chr
m2 or urine ACR3.5 mg/mmol); eGFRcr, creatinine-based estim
glomerular filtration rate; OR, odds ratio; UACR, urinary albumin-
aModel 1: adjusted for sex and age at CKD measurements (da
bModel 2: adjusted for sex, age at CKD measurements, and ov
cModel 3: adjusted for sex, age at CKD measurements, and ovthan the ORs reported in the present study, differences
282in definition of both the exposure and outcome make
comparison difficult.
Associations between early-life overweight and
many adverse health outcomes in later life are now
acknowledged,26 and several previous studies have
looked in more detail at specific patterns of early-life
weight gain. In the same cohort as the present study,
Hardy et al27 highlighted excessive pubertal BMI gain
as being associated particularly strongly with later
blood pressure. Our observation that the pubertal-
onset overweight latent class seemed at somewhat
higher risk of later CKD than the always-overweight
latent class hints at a similar pattern for CKD.
Previous studies also have found children who
were overweight before puberty but returned to nor-
mal weight during puberty to have similar levels of
later blood pressure28 and other cardiovascular risk
factors29 as those who remained normal weight
throughout. Our finding that CKD risk did not differ
between the prepubertal-only and never-overweight
latent classes is in agreement with these previous
results.
Studies also have suggested that individuals who
were born small but then rapidly gained weight during
early life are at particularly high risk of later hyperten-
weight Latent Class, Adjusted for Later-Life Overweight
Model 1 Overweight at
Age 36 yb
Model 1 Overweight at Age
53 yc
OR (95% CI) P OR (95% CI) P
1.00 (reference) — 1.00 (reference) —
0.94 (0.61-1.43) 0.8 0.98 (0.64-1.48) 0.9
1.01 (0.54-1.86) 0.9 1.16 (0.64-2.12) 0.6
1.00 (reference) — 1.00 (reference) —
1.11 (0.64-1.92) 0.7 1.16 (0.67-2.02) 0.6
1.54 (0.82-2.86) 0.2 1.80 (0.95-3.38) 0.07
1.00 (reference) — 1.00 (reference) —
0.87 (0.57-1.34) 0.5 0.91 (0.59-1.40) 0.7
1.09 (0.57-2.06) 0.8 1.25 (0.66-2.39) 0.5
1.00 (reference) — 1.00 (reference) —
0.93 (0.69-1.24) 0.6 0.97 (0.72-1.30) 0.8
1.18 (0.80-1.75) 0.4 1.39 (0.95-2.04) 0.09
kidney disease (defined as eGFRcr or eGFRcys60 mL/min/1.73
glomerular filtration rate; eGFRcys, cystatin C–based estimated
inine ratio.
eated from Table 2).
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Childhood Overweight and CKD at Age 60-64overweight latent class identified in the present analy-
sis was found to have a relatively high mean birth
weight in both males and females, so our results
cannot be explained by this pathway.
The mechanisms relating early-life BMI to later
CKD are not well researched. Overweight children
are at higher risk of developing high blood pressure
and diabetes, although evidence for effects indepen-
dent of adulthood overweight is lacking.26 Over-
weight may have independent associations with blood
pressure that may precede decreased kidney func-
tion.32 Animal studies suggest that obesity is followed
by initial glomerular hyperfiltration, the development
of albuminuria, and subsequent decline in eGFR.33,34
This may explain why we did not observe strong
associations of early-life overweight with UACR; one
could speculate that at age 60-64 years, those who
were overweight from early in life may well have
passed through the early albuminuria stage, although
the data do not allow the sequence of events to be
disentangled.
There are many strengths to this analysis. BMI
measurements were available at regular intervals
throughout early life and calculating overweight sta-
tus using age-specific cutoffs allowed the variability
in actual ages at measurement to be taken into ac-
count. Furthermore, the availability of several differ-
ent measures of CKD allowed a more thorough analy-
sis.
The use of full information maximum likelihood in
the longitudinal latent class analysis allowed the inclu-
sion of all study members with at least one early-life
BMI measurement under the assumption of missing at
random.20 The longitudinal latent class analysis mod-
els fit the data well and the resultant latent classes
were clearly separated and easily interpreted.
Cohort members remaining in the NSHD at the
time of data collection at age 53 years35 and at age
60-64 years12 have been determined as generally
representative of native-born adults living in England,
Scotland, and Wales. We thus are confident that our
analysis sample retained the representativeness of the
study population as a whole. Use of multiple imputa-
tion allowed us to account for the potential bias
caused by missing data.
There also were limitations to the study. Calcula-
tion of eGFR, rather than measuring GFR directly,
may have resulted in some misclassification of CKD.
The lack of repeated measurements of kidney func-
tion meant that we were unable to ascertain CKD
using the recommended definition of reduced kidney
function for at least 3 months.16 This is likely to
introduce nondifferential misclassification, meaning
that the true association is even stronger than de-
scribed here. In addition, the low prevalence of CKD
Am J Kidney Dis. 2013;62(2):276-284in this cohort resulted in low statistical power. Al-
though the similarity in findings across the different
measures of CKD and cystatin C suggests robustness
to our findings, it is important that they are replicated
in larger general population cohorts. Finally, although
we had good coverage of different UK regions and
social class groupings, because the NSHD study popu-
lation is all white, our findings cannot necessarily be
extrapolated to the nonwhite British population.
It should be noted that members of this cohort
experienced childhood in the 1950s, when overweight/
obesity was far less prevalent. Only 7% of study
members were in the pubertal-onset or always-
overweight latent classes, whereas 40% of modern
children in the Americas and Europe are thought to be
overweight or obese.3 Thus, the absolute impact of
any effect of early-life overweight on CKD is likely to
be substantial at the population level.
In conclusion, being overweight throughout early
life or becoming overweight in the period from pu-
berty to age 20 years was found to be associated with
CKD in later life. Reducing or preventing overweight
in early life may significantly reduce the burden of
CKD in the population.
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Table S1: Prevalence of overweight at each age in early life in
the MRC NSHD.
Table S2: Linear regression coefficients for cystatin C level at
age 60-64 by early-life overweight latent class.
Table S3: ORs for CKD at age 60-64 by early-life overweight
latent class, by complete case analyses.
Table S4: Linear regression coefficients for cystatin C level at
age 60-64 by early-life overweight latent class, by complete case
analyses.
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